FDAnews Device Daily Bulletin

Brainsway Starts Bipolar Disorder Trial

Aug. 21, 2012
A A
Brainsway has begun a second multicenter trial of its deep TMS (transcranial magnetic stimulation) device for the treatment of bipolar disorder (manic depression). Sunday, the company announced it had signed with 18 medical centers in Israel, Canada, and the U.S.
Globes